Skip to main content
. Author manuscript; available in PMC: 2019 May 9.
Published in final edited form as: Nature. 2019 Feb 27;567(7749):525–529. doi: 10.1038/s41586-019-0979-8

Extended Data Fig. 4. Deletion of NR4A1 in T cells results in overexpression of IL-2 and IFN γ.

Extended Data Fig. 4

a, qRT–PCR measurement of expression of Nr4a1, Il2 and Ifng in wild-type and Nr4a1−/− CD4+ and CD8+ T cells stimulated with plate-coated anti-CD3 and anti-CD28 at indicated time points. b , Flow cytometry analysis of IFNγ and IL-17A expression in wild-type and Nr4a1−/ − CD4+ and CD8+ T cells from lymph nodes (LN) and spleens (SP). c, ELISA measurement of IFNγ and IL-2 expression in splenocytes from wild-type and Nr4a1−/ − mice in the context of food oral tolerance. PBS-treated mice were used as a control group. *P < 0.05. OD, optical density. d, Equal amounts of CD45.1+ wild-type and CD45.2+Nr4a1−/− bone marrow cells (4 × 106 per mouse) were transferred into Rag1−/− mice. Flow cytometry analysis of CD4+FOXP3+ Treg cells in thymus, spleen and lymph nodes (LN) from chimeric mice two months after reconstitution. Six-week-old mice; n = 3 per group (ac); n = 4 per group (d). P values were calculated using a two-sided unpaired Student’s t-test. N.S., not significant. All data are representative of two independent experiments and graphs show mean ± s.d.